Table 1:

Baseline demographic and clinical characteristics

CharacteristicTreatment group; no. (%) of participants
No probiotic
n = 494
Probiotic
n = 515
No gum
n = 330
Sorbitol gum
n = 337
Xylitol gum
n = 342
Age group
 Adults (≥ 15 yr)381/482 (79.0)408/504 (81.0)265/325 (81.5)268/334 (80.2)256/327 (78.3)
 Children (3–15 yr)101/482 (21.0)96/504 (19.0)60/325 (18.5)66/334 (19.8)71/327 (21.7)
No. of episodes of sore throat in 3 mo before study
 086/479 (18.0)107/507 (21.1)69/325 (21.2)55/336 (16.4)69/325 (21.2)
 1117/479 (24.4)124/507 (24.5)93/325 (28.6)78/336 (23.2)70/325 (21.5)
 2120/479 (25.1)119/507 (23.5)61/325 (18.8)92/336 (27.4)86/325 (26.5)
 ≥ 3156/479 (32.6)157/507 (31.0)102/325 (31.4)111/336 (33.0)100/325 (30.8)
Past tonsillectomy51/494 (10.3)55/515 (10.7)37/330 (11.2)36/337 (10.7)33/342 (9.6)
Ever smoked176/473 (37.2)186/490 (38.0)113/316 (35.8)130/329 (39.5)119/318 (37.4)
Clinical signs and symptoms at first consultation
 Substantial pharyngeal inflammation321/482 (66.6)342/503 (68.0)214/323 (66.2)237/333 (71.2)212/329 (64.4)
 Cough258/486 (53.1)274/505 (54.2)185/326 (56.7)167/335 (49.9)180/330 (54.5)
 Temperature > 37.5°C39/487 (8.0)25/506 (4.9)22/327 (6.7)23/334 (6.9)19/332 (5.7)
 Pus on tonsils158/479 (33.0)151/502 (30.1)93/320 (29.1)105/333 (31.5)111/328 (33.8)
 Cervical nodes260/471 (55.2)292/494 (59.1)168/316 (53.2)200/329 (60.8)184/320 (57.5)
Duration of illness > 7 d (before consultation)107/481 (22.2)109/505 (21.6)73/323 (22.6)73/333 (21.9)70/330 (21.2)